Heather Whitaker, Beth Findlay, Jana Zitha, Rosalind Goudie, Katie Hassell, Josie Evans, Panoraia Kalapotharakou, Utkarsh Agrawal, Beatrix Kele, Mark Hamilton, Catherine Moore, Rachel Byford, Julia Stowe, Chris Robertson, Anastasia Couzens, Gavin Jamie, Katja Hoschler, Kathleen Pheasant, Elizabeth Button, Catherine Quinot, Tim Jones, Sneha Anand, Conall Watson, Nick Andrews, Simon de Lusignan, Maria Zambon, Christopher Williams, Simon Cottrell, Kimberly Marsh, Jim McMenamin, Jamie Lopez Bernal
{"title":"英国 2023/2024 年流感季节初级和二级护理中流感疫苗的临时有效性。","authors":"Heather Whitaker, Beth Findlay, Jana Zitha, Rosalind Goudie, Katie Hassell, Josie Evans, Panoraia Kalapotharakou, Utkarsh Agrawal, Beatrix Kele, Mark Hamilton, Catherine Moore, Rachel Byford, Julia Stowe, Chris Robertson, Anastasia Couzens, Gavin Jamie, Katja Hoschler, Kathleen Pheasant, Elizabeth Button, Catherine Quinot, Tim Jones, Sneha Anand, Conall Watson, Nick Andrews, Simon de Lusignan, Maria Zambon, Christopher Williams, Simon Cottrell, Kimberly Marsh, Jim McMenamin, Jamie Lopez Bernal","doi":"10.1111/irv.13284","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital settings in Scotland and hospital settings in England.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A test negative design was used to estimate vaccine effectiveness.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Estimated vaccine effectiveness against all influenzas ranged from 63% (95% confidence interval 46 to 75%) to 65% (41 to 79%) among children aged 2–17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18–64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>During a period of co-circulation of influenza A(H1N1)pdm09 and A(H3N2) in the United Kingdom, evidence for effectiveness of the influenza vaccine in both children and adults was found.</p>\n </section>\n </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.13284","citationCount":"0","resultStr":"{\"title\":\"Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom\",\"authors\":\"Heather Whitaker, Beth Findlay, Jana Zitha, Rosalind Goudie, Katie Hassell, Josie Evans, Panoraia Kalapotharakou, Utkarsh Agrawal, Beatrix Kele, Mark Hamilton, Catherine Moore, Rachel Byford, Julia Stowe, Chris Robertson, Anastasia Couzens, Gavin Jamie, Katja Hoschler, Kathleen Pheasant, Elizabeth Button, Catherine Quinot, Tim Jones, Sneha Anand, Conall Watson, Nick Andrews, Simon de Lusignan, Maria Zambon, Christopher Williams, Simon Cottrell, Kimberly Marsh, Jim McMenamin, Jamie Lopez Bernal\",\"doi\":\"10.1111/irv.13284\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital settings in Scotland and hospital settings in England.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>A test negative design was used to estimate vaccine effectiveness.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Estimated vaccine effectiveness against all influenzas ranged from 63% (95% confidence interval 46 to 75%) to 65% (41 to 79%) among children aged 2–17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18–64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>During a period of co-circulation of influenza A(H1N1)pdm09 and A(H3N2) in the United Kingdom, evidence for effectiveness of the influenza vaccine in both children and adults was found.</p>\\n </section>\\n </div>\",\"PeriodicalId\":13544,\"journal\":{\"name\":\"Influenza and Other Respiratory Viruses\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-05-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.13284\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Influenza and Other Respiratory Viruses\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/irv.13284\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.13284","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
Background
We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital settings in Scotland and hospital settings in England.
Methods
A test negative design was used to estimate vaccine effectiveness.
Results
Estimated vaccine effectiveness against all influenzas ranged from 63% (95% confidence interval 46 to 75%) to 65% (41 to 79%) among children aged 2–17, from 36% (20 to 49%) to 55% (43 to 65%) among adults 18–64 and from 40% (29 to 50%) to 55% (32 to 70%) among adults aged 65 and over.
Conclusions
During a period of co-circulation of influenza A(H1N1)pdm09 and A(H3N2) in the United Kingdom, evidence for effectiveness of the influenza vaccine in both children and adults was found.
期刊介绍：
Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases.
Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
